ACCHO Leads Hepatitis C Elimination Effort
Bulgarr Ngaru Medical Aboriginal Corporation (BNMAC), Burnet Institute and the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) are joining forces to help stop new infections and reduce severe illness due to hepatitis C infection among Aboriginal communities in northern NSW.
Aboriginal people represent around 8% of Australians living with chronic hepatitis C infection, while comprising only 3% of the population. They are four times more likely not to be included in hepatitis C surveillance data, which means many will miss out on effective treatments if they remain undiagnosed. There are also barriers that prevent testing, treatment and continuing with hepatitis care, including the need for trained staff who can engage in culturally sensitive ways, as well as the stigma felt by Aboriginal people with hepatitis C, which studies have shown reduces their intention to take up treatment.
The project brings together Bulgarr Ngaru’s extensive knowledge of Aboriginal communities in northern NSW; Burnet’s expertise in implementation research, surveillance, monitoring and evaluation; and ASHM’s track record in delivering clinical education in blood borne viruses including viral hepatitis.
To view BNMAC’s announcement in full here.